India Cancer Treatment Market Analysis, 2020 market research report depicts a deep-dive market analysis and statistics of India Cancer Treatment Market. The research study provides regional and country-wise market size, market forecast, CAGR market segmentation, market shares of regions, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
Continuous growth in the cancer cases owing to changing eating habits, food adulteration, environmental changes, growth in chemical establishments, etc. are the major factors for escalating cancer cases in India. The sedentary lifestyle and excessive intake of junk food have been leading to an increase in the number of cancer patients day by day. Moreover, the consumption of tobacco in the country is burgeoning, thereby mounting the total number of deaths due to tobacco cancer It is estimated that one woman dies of cervical cancer every 8 minutes in India due to cancer, according to the National Institute of Cancer Prevention and Research. Of every two women newly diagnosed with breast cancer, one woman dies of it in India.
According to MarkNtel Advisors’ research report titled “India Cancer Treatment Market Analysis, 2020”, the India Cancer Treatment Market is anticipated to grow at a substantial CAGR during 2020-25. The total number of deaths due to cancer in India were more than 0.8 million in 2019.
Owing to extensive investments in R&D and a rise in cancer awareness among individuals, the need for timely diagnosis and preventive care is surging at an exponential pace. Additionally, India has witnessed remarkable opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated in this industry.
The cancer incidence rates in several states of India such as Madhya Pradesh, Odisha, Assam, Uttarakhand, Himachal Pradesh, Punjab, Haryana, Delhi, Maharashtra, Karnataka, etc., was above 82% in 2020. It has been found that lip, oral, breast, and cervical cancer treatment acquired more than 50% of the market share in 2019, as stated in MarkNtel Advisors’ research report “India Cancer Treatment Market Analysis, 2020”.
Immunotherapy Segment Attaining Considerable Growth
The targeted therapy segment attained the largest market growth during 2015-19. This is due to the ability of targeted therapies to kill malignant cells only, advanced efficacy, and higher survival rates associated with their use. The immunotherapy segment is expected to show the fastest growth during the forecast period 2020-25. This is associated with intensification in the incidences of cancer in India and the lack of related medical assistance in the country.
According to MarkNtel Advisors, the key players with a considerable market share in the India Cancer Treatment market include Amgen, AstraZeneca Plc, Merck and Co., Novartis AG, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Celgene Corporation, Bristol-Myers Squibb, F. Hoffmann-La-Roche Ltd., Johnson and Johnson, etc.